Education
About Us
Working with TipRanks
Follow Us
MariMed Inc (MRMD)
OTHER OTC:MRMD
Earnings Data
Report Date
Mar 11, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
>-0.01Last Year’s EPS
-0.02Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call reflected a mix of positive and negative aspects. MariMed reported sequential growth in revenue and positive cash flow, driven by strong performance in Delaware and strategic expansion into the hemp market. However, challenges in retail revenue, increased net losses, and exit from the Missouri market indicate ongoing industry pressures.Company Guidance
Sequential Growth in Wholesale and Retail Revenue
MariMed reported sequential growth in both wholesale and retail revenue. Wholesale sales in Illinois increased by 23% despite a statewide decline of 1.5%, and sales in Massachusetts increased 5% despite a 2% statewide decline.
Strong Performance in Delaware
Delaware saw a 48% sequential increase in retail revenue driven by the start of adult-use sales, broader product availability, and successful brand activation. MariMed is the largest producer in the state.
Wholesale Revenue Growth
Wholesale revenue grew 5% sequentially and 11% year-over-year, now accounting for 44% of product revenue, up from 43% last quarter.
Expansion into Hemp Market
MariMed announced entry into the hemp market, with plans to launch a hemp-based THC version of Vibations in Rhode Island by Q1 2026. The hemp beverage market is projected to nearly double by 2029.
Positive Cash Flow and Cost Discipline
MariMed generated $2.7 million in cash flow from operations, a significant increase from $297,000 in the previous quarter. Operating expenses were flat sequentially and down 4% year-over-year.
MRMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
MRMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 05, 2025 | $0.11 | $0.10 | -9.09% |
Aug 06, 2025 | $0.11 | $0.10 | -9.09% |
May 07, 2025 | $0.10 | $0.10 | 0.00% |
Mar 05, 2025 | $0.12 | $0.11 | -8.33% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does MariMed Inc (MRMD) report earnings?
MariMed Inc (MRMD) is schdueled to report earning on Mar 11, 2026, TBA (Confirmed).
What is MariMed Inc (MRMD) earnings time?
MariMed Inc (MRMD) earnings time is at Mar 11, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MRMD EPS forecast?
MRMD EPS forecast for the fiscal quarter 2025 (Q4) is >-0.01.